Neutral amphiphilic triblock ABA copolymers are of great interest to solubilize hydrophobic drugs. We reported that a triblock ABA copolymer consisting of methyl-2-oxazoline (MeOx) and tetrahydrofuran (THF) (MeOx 6 -THF 19 -MeOx 6 ) (TBCP2) can solubilize curcumin (Cur) a very hydrophobic molecule exhibiting multiple therapeutic effects but whose insolubility and low stability in water is a major drawback for clinical applications. Here, we provide evidences by flow cytometry and confocal microscopy that Cur penetration in normal and DF508-CFTR human airway epithelial cell lines is facilitated by TBCP2. When used on DF508-CFTR cell lines, the Cur/TBCP2 formulation promotes the restoration of the expression of the CFTR protein in the plasma membrane. Furthermore, patch-clamp and MQAE fluorescence experiments show that this effect is associated with a correction of a Cl À selective current at the membrane surface of F508del-CFTR cells. The results show the great potential of the neutral amphiphilic triblock copolymer MeOx 6 -THF 19 -MeOx 6 as carrier for curcumin in a Cystic Fibrosis context. We anticipate that other MeOx n -THF m -MeOx n copolymers could have similar behaviours for other highly insoluble therapeutic drugs or cosmetic active ingredients.
Introduction
Many chemotherapeutic drugs or cosmetic active ingredients are very insoluble in water compromising their effectiveness and clinical applications. Delivery of drugs into the cells relies on many constraints such as solubilisation, endocytosis or crossing through the membrane lipid bilayer. In this context, more particularly, polymer-based synthetic vectors offer advantages such as relative simplicity of production, safety and versatility. Polyester/ether ABA triblock copolymers developed as drug delivery system comprise poly(D,L-lactide-block-ethylene oxide-block-D,L-lactide) (PLA-PEO-PLA), poly[(D,L-lactide-co-glycolide)-block-ethylene oxideblock-(D,L-lactide-co-glycolide)] (PLGA-PEO-PLGA) and poly(e-ca prolactone-block-ethylene oxide-block-e-caprolactone (PCL-PEO-PCL) [1] . PPO-PEO-PPO copolymers, Pluronic polymers, have been studied quite extensively thanks to the formation of core-shell micelles comprising the polyethylene oxide (PEO) block as the hydrophilic shell of the corona and the polypropylene oxide (PPO) block as the core [2, 3] . Such copolymers have already received large attentions to solubilize hydrophobic molecules for drug delivery [4, 5] . Certain Pluronic polymers have shown capacity to pass the blood-brain barrier [2] . They have even demonstrated their ability to increase the biodistribution after oral delivery of molecules poorly soluble in water such as genestein [6] . In a clinical phase I study, doxorubicin bound to a pluronic polymer has demonstrated an increased efficacy compared to free doxorubicin [7] . In the field of immunization with proteins and peptides, neutral amphiphilic copolymers have increased significantly the humoral and cellular responses after intravenous injection [8] . Lutrol has provided efficient gene expression in lung and skeletal muscles upon intratracheal and intramuscular co-injection in mice of plasmid DNA, respectively [9, 10] . Moreover, DNA vaccination has been induced with DNA/amphiphilic block copolymer nanospheres [11] .
Poly(2-oxazolines) based polymers are also interesting biomaterials to solubilize water insoluble molecules [12] . Formulations based on poly(2-oxazoline) polymeric micelles and the effect of parameters related to the structure, formulation, additives and toxicity have been described [4, [13] [14] [15] [16] . These reported properties allowed to conclude to the high potential of poly(2-oxazoline) block copolymers, for instance in cancer treatments. Poly(2-methyl-2-oxazoline-b-2-butyl-2-oxazoline-b-2-methyl-2-oxazo line (p(MeOx-b-BuOx-b-MeOx)) has been found to solubilize high quantity of paclitaxel, a very low soluble molecule in aqueous media exhibiting powerful antineoplastic effect, and demonstrated an improved therapeutic effect in xenograft mice tumor models [17, 18] . A clinical phase I study with a rotigotine polyoxazoline conjugate has been initiated from data obtained in Parkinson's disease [19] .
Recently, we have reported the synthesis and characterization of an original family of poly(2-methyl-2-oxazoline-b-tetrahydrofuran-b-2-methyl-2-oxazoline) (MeOx-THF-MeOx) neutral amphiphilic triblock copolymers and showed that some of them solubilized curcumin [20] . Curcumin (diferuloylmethane) (Cur), the natural component of the plant ''Curcuma Longa" exhibits multiples therapeutic effects but is very insoluble in water [21] . This is a safe drug even at high doses, but is rapidly metabolized and poorly absorbed by the cells [22] . Curcumin is proposed for treatment of various pulmonary diseases including Asthmas, cancer and Cystic Fibrosis [23] . In order to evidence the interest of curcumin solubilisation by MeOx-THF-MeOx copolymers, we decided to investigate its influence in a Cystic Fibrosis context. Indeed, curcumin has been proposed to treat Cystic fibrosis (CF), the most lethal genetic disease caused by mutations in the gene encoding the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Cl À channel resulting in abnormal chloride transport at the plasma membrane of many tissues and organs [24] . DF508 is the most common mutation of CFTR causing a misfolding of the CFTR protein and its retention in the endoplasmic reticulum (ER) for subsequent proteolytic degradation by the ubiquitin-proteasome pathway [25] . Cur can partially compensate the ER retention of the defective CFTR protein, both in vitro in appropriate cell lines and in vivo in F508del-CFTR mice [26, 27] . However, the insolubility and poor stability of Cur in water explain some disappointing results observed in mice treated with Cur [28] . Thus, it appeared for us that curcumin was a good example to test the potential of our amphiphilic copolymers to carry hydrophobic molecules. Here, we report that the MeOx 6 -THF 19 -MeOx 6 (TBCP2) copolymer facilitates penetration of curcumin in F508del-CFTR cells and preserves the capacity of curcumin to restore a functional CFTR protein.
Material and methods
All reagents were purchased from Sigma (St. Quentin Fallavier, France) unless otherwise stated.
Polymer synthesis
Poly(2-methyl-2-oxazoline) -b -poly(tetrahydrofuran) -bpoly(2-methyl-2-oxazoline) triblock copolymer (TBCP2). The copolymer was synthesized as described [20] . Briefly, to a 250 mL reaction flask containing 236 mmol (17 g) of dry THF, 13.9 mmol (3.91 g) of trifluoromethanesulfonic anhydride (Tf 2 O) was added at À9°C. The reaction mixture was stirred during 15 min and the polymerization was quenched by adding 55.6 mmol (4.7 g) of MeOx at À9°C. Evaporation of residual THF under reduced pressure yielded to a pTHF prepolymer as a white solid. This solid was dissolved in 40 mL of dry acetonitrile and the temperature was increased to 80°C. MeOx (88.2 mmol; 7.5 g) was added and the solution stirred for 24 h. The reaction was quenched by 4 mL of 2 M sodium carbonate solution and stirred for 1 h at room temperature. The copolymer was dried and the crude yield was 80%. A chloroform/water extraction was then conducted, the organic phase evaporated and dried for 2 days under vacuum. The triblock copolymer had hydroxyl and ester end functions (47%) as determined by 1 
Curcumin solubilisation
Curcumin was purified by crystallisation in hot ethanol. Curcumin (10 g) was solubilized in 20 mL pure ethanol under reflux. The hot solution was filtrated, the filtrate was left to cool down and the Cur was collected by filtration (yield 60%). A 0.2% TBCP2 solution was prepared by adding 5 ml H 2 O to 10 mg TBCP2 and vigorous agitation with vortex until complete dissolution. Then 2 mg of Cur were added to the TBCP2 solution, the Cur/TBCP2 (400:2000; lg: lg) mixture was vortexed and then sonicated for 5 min at 20°C at 37 kHz. The solution was then clarified by centrifugation (14,100g for 10 min) to remove any precipitate.
Cells and cell culture
The CFBE41o-human bronchial epithelial (homozygous for the F508del mutation) [29] and RCFTE29o-human tracheal epithelial (homozygous for the F508del mutation) [30] cell lines carrying the F508del CFTR mutation (so called CF cells) and the 16HBE14o-normal human bronchial epithelial cell line [31] (generous gifts from Dieter Gruenert, San Francisco, CA, U.S.A.) were cultured at 37°C in a 5% CO 2 -humidified incubator in 20 ml MEM with Earle's Salts (PAA Laboratories), 0.4% Penicillin (40 Units/ ml)/Streptomycin (40 lg/ml) (PAA Laboratories), 2 mM lGlutamine (PAA Laboratories), supplemented with 10% heatinactivated fetal bovine serum (PAA Laboratories). Tissue culture plastic wares (75 cm 2 ) were coated for 20-30 min at 37°C with MEM with Earle's Salts containing fibronectin (0.01 mg/ml), collagen (0.03 mg/ml) and bovine serum albumin (BSA) (0.1 mg/ml). The culture medium was changed every 2 days. The absence of mycoplasma in cell cultures was determined by using MycoAlert 
Immunofluorescence assays
Immunofluorescence was carried out with the following antibodies: mouse anti-human CFTR antibodies (Clone M3A7, LifeSpan Biosciences) (dilution 1/50), rabbit anti-calreticulin antibodies (LifeSpan Biosciences) (dilution 1/100), goat anti-calnexin antibodies (C20, Santa Cruz Biotechnology) (dilution 1/100), goat anti-ERGIC-53 antibodies (A-18, Santa Cruz Biotechnology) (dilution 1/100), Alexa Fluor 568 goat anti-mouse antibodies (Invitrogen) (dilution 1/200), Alexa Fluor 568 donkey anti-goat antibodies (Invitrogen) (dilution 1/200), Cy5 sheep anti-mouse antibodies (Jackson Immunoresearch) (dilution 1/100).
Confocal microscopy
The cells (1.4 Â 10 4 ) were seeded on glass coverslips (14 mm diameter) in 2 cm 2 well of a 4-well plastic culture plate. Intracellular locations were performed by immunofluorescence. The cells were washed several times with ice-cold PBS, fixed in cold methanol (90% in PBS) for 30 min at À20°C, washed several times with PBS containing 0.5% bovine serum albumin (PBS-0.5%BSA). Coverslips were incubated with primary antibodies in PBS-1%BSA for 1 h at 20°C, washed with PBS-0.5%BSA and then incubated for 45 min at 20°C with secondary fluorescent antibodies in PBS-1% BSA. After several washes with PBS, coverslips were mounted in Vectashield (Vector Laboratories, Inc., Burlingame, CA, USA). Confocal laser scanning microscopy (CLSM) was performed using the Zeiss Axiovert 200 M microscope coupled with the Zeiss LSM 510 scanning device (Carl Zeiss Co. Ltd., Iena, Germany). The inverted microscope was equipped with a Plan-Apochromat 63X objective (NA = 1.4). The fluorescence was measured at either 560 nm upon excitation at 543 nm (Alexa Fluor 568), or 660 nm upon excitation at 633 nm (Cy5).
Electrophysiological measurements
The cells were cultured on a glass coverslip that was transferred to the experimental chamber of an upright microscope (BX51WI, Olympus Corporation, Tokyo, Japan). Patch-clamp experiments were performed at 21-23°C. Cells were placed in continuously flowing (1-2 ml/min) bath solution containing (mM): 150 NaCl; 6 CsCl; 1 CaCl 2 ; 1 MgCl 2 ; 10 D-glucose; 10 HEPES (adjusted to pH 7.4 with Tris) and identified at 60Â magnification with a CCD camera (XC-ST70CE, Sony). Somatic whole-cell recordings were performed as previously described [32] . Briefly, low resistance (4-6 MX) patch-pipettes pulled on a vertical puller (PB-7, Narishige, Tokyo, Japan) from borosilicate capillaries (Clark Electromedical Instruments, Edenbridge, UK) were filled with internal solution containing (mM): 100 l-aspartic acid; 94 CsOH; 26 CsCl; 14 NaCl; 1 MgCl 2 ; 3 MgATP; 1 EGTA; 10 HEPES (adjusted to pH 7.3 with Tris). Signals were amplified using the MultiClamp 700B amplifier (Axon Instruments, Foster City, CA). Series resistance was monitored continuously and was typically compensated by 60-70% in whole-cell configuration. Voltage-clamp recordings were filtered at 4 kHz, sampled at 10 kHz using a data acquisition board (Digidata 1322A, Axon Instruments) operated by Pclamp10 software (Axon Instruments). Off-line analysis was performed using Clampfit10 (Axon Instruments) and Origin8 (Origin Lab Corporation, Northampton, MA). 16HBE14o-and RCFTE29o-cells were cultured under control conditions or in the presence of Cur/TBCP2 treatment. Currents were elicited by voltage steps applied from À110 mV to +70 mV (10 mV increments, 400 ms duration) from a holding potential (HP) of À40 mV. Steady-state current amplitude was measured at the end of the pulse and normalized to the cell membrane capacitance (17.6 ± 1.5 pF, n = 19 on 16HBE14o-cells;
22.1 ± 1.2 pF, n = 28 on RCFTE29o-cells).
MQAE fluorescence assay
The Cl À channel activity of CFTR was assessed on 16HBE14o-and CFBE41o-cells using the halide-sensitive fluorescent probe MQAE [33] . Cells were loaded with MQAE intracellular dye by incubation for 8 min at 37°C in a hypotonic medium (mM) (110 NaI, 
Results

Curcumin solubilisation and penetration into CF and normal airway epithelial cell lines
The MeOx 6 -THF 19 -MeOx 6 ABA copolymer (TBCP2) of 2400 g mol À1 was composed of 12 poly(2-methyl-2-oxazoline) (MeOx) hydrophilic blocks A and 19 polytetrahydrofuran (THF) hydrophobic blocks B (Fig. 1A) . The chemical shifts of the pTHF blocks were at 1.61 ppm and 3.40 ppm, those of the pMeOx ones at 2.13 ppm (CH 3 groups) and 3.42 ppm and those of the telechelic CH 2 groups adjacent to the end hydroxyl functions at 3.78 ppm (Fig. 1C) . The surprising high dispersity (Ɖ = 4.5) was attributed to the low molar mass of the pTHF block associated to the reversible cationic ring opening polymerization of THF. The standard conditions for MeOx polymerization allowed expecting a much better control of these blocks synthesis as previously reported [34] . The amphiphilic feature in aqueous solution and self-assembling to form micelles of TBCP2 were determined by different techniques including Nile Red fluorescence spectroscopy (F), isothermal titration calorimetry (ITC) and dynamic light scattering (DLS) [20] . The critical micellar concentration was 3
determined by F, ITC and DLS, respectively. In a 0.2% solution in water, TBCP2 formed micelles with a hydrodynamic diameter of 16 ± 1.4 nm as determined by DLS (Fig. 1D ). The solubilisation of 2 mg Cur (400 lg/ml; 1.1 mM) was achieved by mixing, vortexing and then sonicating 2 mg Cur in 5 ml of 0.2% TBCP2 in water (Fig. 1B) . In contrast, Cur was completely insoluble in water in the absence of TBCP2 (Fig. 1B) . The resulting Cur/TBCP2 formulation (17 wt.%) formed nanoparticles of 255 ± 30 nm (Fig. 1D) . We then tested whether the Cur/TBCP2 formulation allowed for Cur uptake by the cells. For this purpose, two CF (RCFTE29o-and CFBE41o-) and one normal (16HBE14o-) human airway epithelial cell lines were incubated in complete culture medium at 37°C in the presence of Cur solubilized in TBCP2 or TBCP2 without Cur. After 2 h incubation, Cur location was analysed by fluorescence microscopy thanks to Cur fluorescence at 520 nm upon excitation at 488 nm. As shown in Fig. 2 , the fluorescence was in the cytoplasm with Cur/TBCP2 showing penetration of Cur in these cell lines. In contrast, no fluorescence was detected in the cells incubated with TBCP2 in the absence of Cur or the supernatant of Cur in PBS (Fig. 2) . The Cur fluorescence intensity associated with the cells was measured by flow cytometry after 2 h incubation with various dilution of the Cur/TBCP2 formulation. As shown in We evaluated by confocal microscopy the uptake of the copolymer by incubating those cell lines for 4 h at 37°C with a Cur/Rho-TBCP formulation (Fig. 4) . The images showed that the copolymer did not enter deeply into the cytoplasm of RCFTE29o-cells while curcumin entered the cells. It was mostly remained close to the cell surface either at and/or under the cell surface while a few amount of polymer was inside the cells. Regarding the bronchial epithelial cells (CFBE41o-and 16HBE14o-cells), the presence of yellow spots in the cytoplasm was indicative of higher TBCP internalization than in the tracheal epithelial cells (RCFTE29o-cells). Next, the evaluation of the effect of curcumin on CFTR in F508del-CFTR cells was studied. The CFTR intracellular location was performed by immunofluorescence and confocal microscopy analysis, and its functionality (assessed via chloride current measurements) by patch-clamp experiments and MQAE fluorescence assay.
Effect of Cur/TBCP2 on CFTR intracellular location
Before testing the Cur/TBCP2 effect, the intracellular distribution of CFTR was examined in F508del-CFTR and normal cells by immunofluorescence and confocal microscopy. The cells were labelled with anti-CFTR antibodies and also with antibodies directed against calreticulin or calnexin which are two quality-control chaperones that bind to misfolded proteins such as the muted CFTR and prevent them from being exported from the ER to the Golgi apparatus for complete glycosylation. The cells were also stained with antibodies directed against ergic-53 because previous observations suggested that F508del-CFTR was also present in the Endoplasmic reticulum intermediate compartment (ERGIC) [35] . Confocal microscopy images showed that in normal (16HBE14o-) cells, CFTR was located at the periphery of the cells or at the plasma membrane (blue spots) and very few colocations (white spots) were observed with calreticulin or calnexin (Fig. 5) . CFTR was logically detected also in ergic-53 en route for its glycosylation in the Golgi. In RCFTE29o-cells, the F508del-CFTR was mostly concentrated in the perinuclear region and strongly colocalized with antibodies directed against calnexin and ergic-53 in line with the retention of the mutated protein in the ER/ERGIC compartments of cells expressing the F508del-CFTR (Fig. 5) . The retention effect in ERGIC looked stronger in RCFTE29o-cells with the presence of many white spots and no blue ones than in CFBE41o-cells. The F508del-CFTR distribution in CFBE41o-looked like that the CFTR in 16HBE14o-cells suggesting localization in the plasma membrane. However, it was reported that the F508del-CFTR was distributed in the cytoplasm of CFBE41o-cells [36] . The CFBE41o-cells are bronchial epithelial cells while the RCFTE29o-cells are from tracheal epithelial cells. The intracellular distribution of the F508del-CFTR could vary with the nature of the pulmonary epithelial tissues [37] . Of note, the F508del-CFTR location in the calreticulin compartment looked weak in the CF cell lines.
When RCFTE29o-cells were incubated overnight with 220 lM Cur solubilized with TBCP2, CFTR was not located in the ER/ERGIC compartment near the nucleus as in absence of Cur but its distribution was similar as in the normal 16HBE14o-cells indicating CFTR redistribution in the presence of Cur (Fig. 6 ). This redistribution after incubation of CFBE41o-cells with the Cur/TBCP2 solution was not as demonstrative as in RCFTE29o-cells (Fig. 6 ). This could be explained by the lower retention of F508del-CFTR in ERGIC of CFBE41o-cells comparatively to RCFTE29o-cells (Fig 5) . As expected, no modification was observed in normal 16HBE14o-cells in which CFTR was mostly at the plasma membrane (Fig. 6) . The images reconstitution of several z steps as well as sections of the z-step gallery passing through the middle of a representative RCFTE29o-cell showed clearly that F508del-CFTR was concentrated at the nucleus periphery in the absence of Cur while it was distributed throughout the cell and at the plasma membrane in the presence of Cur (Fig. 7) . These results evidenced that incubation of F508del-CFTR cells with the Cur/TBCP2 solution promoted the relocation of the CFTR at the plasma membrane.
CFTR current specific activation by Cur/TBCP2 treatment
Whole-cell patch-clamp experiments were carried out to determine the activation of CFTR chloride current after incubation of CF cells with Cur/TBCP2 solution. First, whole-cell patch-clamp experiments were performed in normal (16HBE14o-) and CF (RCFTE29o-) cells in the absence of Cur/TBCP2. The measurement of the associated averaged steady-state current-voltage (I/V) relationships revealed the presence of a high chloride induced current (15.3 ± 2.8 pA/pF) in normal cells (Fig. 8Aa and B black squares) whereas in CF cells (Fig. 8Ab and B , black circles) a weak chloride current (3.1 ± 0.5 pA/pF) was measured at a potential of +60 mV.
In the presence of 10 lM CFTRinh-172 -a specific CFTR inhibitor - [38] the chloride current was strongly inhibited in 16HBE14o-cells (Fig. 8B, white squares) . In contrast the effect was limited in CF cells (Fig. 8B, white circles) . The CFTRinh-172 current sensitivity in 16HBE14o-cells (9.3 ± 2.9 pA/pF at a potential of +60 mV) was 7-fold higher than in RCFTE29o-cells (1.3 ± 0.3 pA/pF). The chloride current measured in both cell lines was also inhibited by 20 lM GlyH-101 -another specific CFTR inhibitor - [39] (data not shown). All together these data demonstrated that chloride currents measured on these different cell lines corresponded to a CFTR chloride current and were in line with those as previously described for these two cell lines [40, 41] . Fig. 9 presents characteristic whole-cell currents in Cur/TBCP2-treated RCFTE29o-cells in the absence and the presence of 10 lM
CFTRinh-172. CFTR currents were equivalently blocked on this cell lines by CFTRinh-172 and GlyH-101, the experiments were then conducted with CFTRinh-172 only. Compared to untreated cells, the incubation with Cur/TBCP2 induced a current enhancement that was strongly inhibited in the presence of CFTRinh-172 (Fig. 9A) . The CFTRinh-172 current sensitivity was calculated as the difference between currents measured prior and after CFTRinh 172 exposure, in the same way as done for Fig. 9B . CFTRinh-172 current sensitivity plotted as current-voltage (I-V) relationships revealed that incubation of RCFTE29o-cells with Cur/TBCP2
(120 lM) induced a statistically significant increase in CFTRinh-172 current sensitivity at all membrane potential tested (Fig. 9B) . Cur/TBCP2 induced a linear conductance typical of a Cl À selective current. At +30 mV, the current density reached 4.5 ± 1 pA/pF with Cur/TBCP2 versus 1 ± 0.6 pA/pF under basal conditions. The observed zero current potential was À39. 
CFTR Cl À activity assessed by MQAE fluorescence assay
The functional measurement of the CTFR expression in the different airway epithelial cells was also assessed by using the chloride fluorescent probe MQAE [33] (Fig. 10B) . (Fig. 10C) . The fluorescence amplitude variation of the fluorescence intensity used as an index of CFTR activity demonstrated a specific restoration of the CFTR activity in CF cells treated with Cur/TBCP2 close to that observed in normal cells (Fig. 10D) . Of note, MQAE fluorescence testing was not performed with RCFTE29o-cells because the functional restoration of F508del-CFTR was convincing by Patch-clamp measurements (Fig 9) . In contrast it was less demonstrative with CFBE41o-cells.
Discussion
Several strategies have been explored to improve solubility and stability of Cur in water. For instance, Cur was conjugated to sugars [42, 43] , amino acids [44] and polyethylene glycol [45, 46] . Formulations with carriers were also explored [47, 48] . For instance, Cur solubility and activity were improved upon inclusion in cyclodextrin [49] or encapsulation in liposomes [50] [51] [52] , chitosan/poly (butyl cyanoacrylate) nanoparticles [53, 54] , PLGA nanoparticles [55] or methoxy poly(ethylene glycol)-block-polycaprolactone diblock copolymers micelles [56] . Cur effect was enhanced in CF mice upon oral administration of Cur encapsulated in biodegradable nanoparticles made of an oil-in-water emulsion mixture of poly (lactic-co-glycolic acid) (PLGA) and poly(vinyl alcohol) [57] . ABA copolymers comprising poly(ethylene oxide) (PEO) block as the hydrophilic moiety and poly(propylene oxide) (PPO) block as hydrophobic moiety forming core-shell micelles were also used. However, PEO polymers due either to the polymer itself or a side product formed during its synthesis can generate various unfavourable effects [58] . Polyoxazoline was proposed as an alternative to PEO [15, 59] and a family of poly(2-methyl-2-oxazoline-b-tetra hydrofuran-b-2-methyl-2-oxazoline) (MeOx-THF-MeOx) neutral amphiphilic triblock copolymers (TBCP) have been synthesized [20] . Our Cur/TBCP2 formulation (17 wt.%) was obtained by solubilisation of Cur (0.5 mg) in a water solution of micelles of TBCP2 copolymer (2 mg/ml; 2400 g mol À1 ). Comparatively, the preparation of 1 mg/ml curcumin with 10 mg/ml of 1,2-dimyristoyl-sn-gly cero-3-phosphocholine and 1,2-dimyristoyl-sn-glycero-3-phos pho-rac-(1-glycerol) liposomes was described [52] ; the preparation of 14 wt.% and 7.6 wt.% curcumin formulations were reported with methoxy poly(ethylene glycol)-block-polycaprolactone diblock copolymers micelles [56] and poly (lactic-co-glycolic acid) (PLGA) and poly(vinyl alcohol) nanoparticles [57] , respectively. With another highly hydrophobic drug, the preparation of a 45 wt.% Paclitaxel formulation was successfully achieved with the MeOx 37 -b-BuOx 23 -b-MeOx 37 , a triblock copolymer of showing that a neutral amphiphilic diblock copolymer -a poly (ethylene oxide-b-4-vinylpyridine) -was able to form transient pores in a lipid artificial membrane allowing the passage of a plasmid DNA of $5 kbp across the model membrane [60] . Here, we have evaluated the biofunctionality of curcumin after solubilisation by TBCP2. For this purpose, we have tested whether the Cur/TBCP2 formulation could restore the expression of a functional CFTR protein at the surface of F508del-CFTR cells. Indeed, F508del-CFTR is not expressed at the plasma membrane because it is retained in the ER/ERGIC compartment by the quality control system involving calreticulin and/or calnexin [61] . Our immunofluorescence analyses performed on two F508del-CFTR cell lines verified that F508del-CFTR colocates with calnexin and calreticulin. They confirmed also that F508del-CFTR colocates with ERGIC-53, a protein specific of the ERGIC compartment as previously reported [35] . p58/ERGIC-53 is a calcium-dependent lectin recognizing mannose that cycles between the ER and the Golgi apparatus and functions as a cargo receptor for a subset of soluble glycoproteins exported from the ER. The lectin domains of ERGIC-53 and calnexin are structurally similar. F508del-CFTR is not exported to the Golgi for maturation but is driven to the cytosolic ubiquitin-proteasome machinery for degradation. It has been shown that ERGIC compartment accumulates proteins on the way for degradation as the precursor of human asialoglycoprotein receptor H2a and free heavy chains of murine class I major histocompatibility complex (MHC) [62] . Significant amounts of various ER resident proteins have been detected in ERGIC indicating that a leak of calnexin from ER into ERGIC might occur [63] . Thus, calnexin could be transiently present in ERGIC which could be a site for the concentration and retrotranslocation of proteins that are transported to the cytosol. That explains colocations between F508del-CFTR and p58/ERGIC-53 observed in the F508del-CFTR cell lines.
Cur was shown to partially compensate the ER retention of the defective CFTR protein in appropriate cell lines and in F508del-CFTR mice [26, 27] . We demonstrate that incubation of F508del-CFTR cell lines with Cur/TBCP2 induces the relocation of the mutated CFTR protein at the plasma membrane. This effect resulted likely from the better cellular penetration of Cur upon solubilisation in the TBCP2 solution. The functionality of CFTR chloride channels in the apical membrane of CF cells after incubation with Cur/TBCP2 is clearly revealed by whole-cell patch-clamp experiments and MQAE fluorescence assay. In the former, the specificity of the activation of CFTR currents is provided by the use of CFTRinh-172 or GlyH-101, two specific CFTR inhibitors that both induce strong inhibition of restored currents in CF cells treated with Cur/TBCP2. CFTRinh-172 is a well-known and widely used specific inhibitor of CFTR channels, without affecting other chloride conductance such as the Ca2
or the volume-sensitive outwardly rectifying Cl À conductance (VSORC). GlyH-101 appears less specific as it inhibits both VSORC and CaCC at concentrations close to those used to inhibit CFTR conductance [64] . Therefore, our calculated CFTRinh-172 current sensitivity was due to CFTR current. The fluorescence assay with the chloride sensitive fluorescent probe MQAE which is quenched in the presence chloride or iodide ions is drastically restored in CF cells after Cur/TBCP2 treatment in response to I À /NO 3 À substitution and cAMP stimulation. All together, these results provide strong evidences that the CFTR relocation leads to a functional chloride channel.
The exact mechanism by which Cur allows the F508del-CFTR relocation is not fully understood. Cur is an inhibitor of the sarcoplasmic/endoplasmic reticulum Ca 2+ -ATPase (SERCA) involved in the translocation of calcium from the cytosol to the sarcoplasmic reticulum lumen [65] [66] [67] . The lectin-like recognition of calreticulin, calnexin and ERGIC-53 that binds to the terminal glucose of the N-oligosaccharide structure of misfolded glycoproteins is calcium-dependent. SERCA inhibition by Cur via the modulation of sarcoplasmic reticulum calcium content could prevent retention of F508del-CFTR in the ER/ERGIC favouring its delivery in the Golgi apparatus for maturation and exocytosis to the plasma membrane. It has also been reported that the trafficking of CFTR to the plasma membrane involves the keratin 8/keratin 18 network of intermediate filaments [68, 69] . An important remodelling in the keratin 18 network has been indeed observed in Cur-treated cells with an increase in the phosphorylation of K18 Ser52 in a calciumindependent manner [70] . This reorganization reduces the intracellular trafficking of organelles mediated by the intermediate filaments and the turnover of some membrane proteins as CFTR. Inhibitions by Cur of the ER retention of F508del-CFTR and its turnover from the plasma membrane could contribute to the or after addition of 10 lM CFTRinh-172 for 10 min (white symbols). All results were expressed as mean ± SEM.
restoration of a functional CFTR in the plasma membrane. Curcumin was proposed to treat Cystic Fibrosis but its multiple therapeutic effects as well as the absence of fully understanding mechanism (s) of action delay its FDA agreement. For this raison, curcumin is often named as pan-assay interference (PAIN) compound, classes of compounds that can interfere with bioassays via a number of different mechanisms [71] .
Conclusion
We demonstrated the great potential of the MeOx 6 -THF 19 -MeOx 6 copolymer to solubilize a very insoluble molecule such as curcumin. In a cystic fibrosis context, we showed that curcumin better penetrated normal and F508del-CFTR human airway epithelial cells and promoted a functional expression of the mutated sensitive currents. I/V curves on cells before treatment (black squares, n = 8), and 16 h treatment with Cur/TBCP2 (black triangles, n = 19). Steady-state current amplitude was measured at the end of the pulse and normalized to the cell capacitance. All results were expressed as mean ± SEM. Statistical significance was assessed using Mann-Whitney non-parametric test, and the significance level was established at p < 0.05 between CFTRinh-172 sensitive currents measured with Cur/TBCP2. CFTR protein in the plasma membrane of the CF cells. More generally, MeOx n -THF m -MeOx n copolymers could help solubilisation of other water insoluble drugs or cosmetic ingredients contributing to their better applications. NaI À (white histograms) expressed as the difference between the maximal fluorescence intensity measured at steady state before and after the change of the respective solutions. Data are means ± SEM. Statistical significance was assessed using a Student's t-test, and the significance level was established at p < 0.05 (*p < 0.05; **p < 0.01; ***p < 0.00.1). ns: non-significant.
